Canlyniadau Chwilio - Agnès Vidal

Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH) gan David C. Tully, Paul V. Rucker, D. CHIANELLI, Jennifer Williams, Agnès Vidal, Phil B. Alper, Daniel Mutnick, Badry Bursulaya, James Schmeits, Xiangdong Wu, Dingjiu Bao, Jocelyn Zoll, Young Kim, Todd Groessl, Peter McNamara, H. Martin Seidel, Valentina Molteni, Bo Liu, Andrew Phimister, Sean B. Joseph, Bryan Laffitte